Selected research
Market Outlook & Growth Opportunities
Global Obesity Surgery Devices Market Outlook and Growth Opportunities 2026
Market perspective
The global Obesity Surgery Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Obesity Surgery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Obesity Surgery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Obesity Surgery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Obesity Surgery Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Obesity Surgery Devices market include Allergan, Apollo Endosurgery, Aspire Bariatrics, IntraPace, Intuitive Surgical, Mediflex Surgical Product, MetaCure, Semiled and Spatz FGIA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Obesity Surgery Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Obesity Surgery Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Obesity Surgery Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Obesity Surgery Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Obesity Surgery Devices Segment by Company
Allergan
Apollo Endosurgery
Aspire Bariatrics
IntraPace
Intuitive Surgical
Mediflex Surgical Product
MetaCure
Semiled
Spatz FGIA
TransEnterix
USGI Medical
Medtronic
Johnson & Johnson
Obesity Surgery Devices Segment by Type
Intragastric Balloons
Gastric Electrical Stimulation
Gastric Bands
Staples
Obesity Surgery Devices Segment by Application
Minimally Invasive Surgical
Non-invasive Surgical
Obesity Surgery Devices Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Obesity Surgery Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Obesity Surgery Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Obesity Surgery Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Obesity Surgery Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obesity Surgery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Obesity Surgery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obesity Surgery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Obesity Surgery Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Obesity Surgery Devices industry.
Chapter 3: Detailed analysis of Obesity Surgery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Obesity Surgery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Obesity Surgery Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Intragastric Balloons
- Gastric Electrical Stimulation
- Gastric Bands
- Staples
Applications
- Minimally Invasive Surgical
- Non-invasive Surgical
Companies covered
- Allergan
- Apollo Endosurgery
- Aspire Bariatrics
- IntraPace
- Intuitive Surgical
- Mediflex Surgical Product
- MetaCure
- Semiled
- Spatz FGIA
- TransEnterix
- USGI Medical
- Medtronic
- Johnson & Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Obesity Surgery Devices Sales Value (2021-2032)
- 1.2.2 Global Obesity Surgery Devices Sales Volume (2021-2032)
- 1.2.3 Global Obesity Surgery Devices Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Obesity Surgery Devices Market Dynamics
- 2.1 Obesity Surgery Devices Industry Trends
- 2.2 Obesity Surgery Devices Industry Drivers
- 2.3 Obesity Surgery Devices Industry Opportunities and Challenges
- 2.4 Obesity Surgery Devices Industry Restraints
3 Obesity Surgery Devices Market by Company
- 3.1 Global Obesity Surgery Devices Company Revenue Ranking in 2025
- 3.2 Global Obesity Surgery Devices Revenue by Company (2021-2026)
- 3.3 Global Obesity Surgery Devices Sales Volume by Company (2021-2026)
- 3.4 Global Obesity Surgery Devices Average Price by Company (2021-2026)
- 3.5 Global Obesity Surgery Devices Company Ranking (2024-2026)
- 3.6 Global Obesity Surgery Devices Company Manufacturing Base and Headquarters
- 3.7 Global Obesity Surgery Devices Company Product Type and Application
- 3.8 Global Obesity Surgery Devices Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Obesity Surgery Devices Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Obesity Surgery Devices Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Obesity Surgery Devices Market by Type
- 4.1 Obesity Surgery Devices Type Introduction
- 4.1.1 Intragastric Balloons
- 4.1.2 Gastric Electrical Stimulation
- 4.1.3 Gastric Bands
- 4.1.4 Staples
- 4.2 Global Obesity Surgery Devices Sales Volume by Type
- 4.2.1 Global Obesity Surgery Devices Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Obesity Surgery Devices Sales Volume by Type (2021-2032)
- 4.2.3 Global Obesity Surgery Devices Sales Volume Share by Type (2021-2032)
- 4.3 Global Obesity Surgery Devices Sales Value by Type
- 4.3.1 Global Obesity Surgery Devices Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Obesity Surgery Devices Sales Value by Type (2021-2032)
- 4.3.3 Global Obesity Surgery Devices Sales Value Share by Type (2021-2032)
5 Obesity Surgery Devices Market by Application
- 5.1 Obesity Surgery Devices Application Introduction
- 5.1.1 Minimally Invasive Surgical
- 5.1.2 Non-invasive Surgical
- 5.2 Global Obesity Surgery Devices Sales Volume by Application
- 5.2.1 Global Obesity Surgery Devices Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Obesity Surgery Devices Sales Volume by Application (2021-2032)
- 5.2.3 Global Obesity Surgery Devices Sales Volume Share by Application (2021-2032)
- 5.3 Global Obesity Surgery Devices Sales Value by Application
- 5.3.1 Global Obesity Surgery Devices Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Obesity Surgery Devices Sales Value by Application (2021-2032)
- 5.3.3 Global Obesity Surgery Devices Sales Value Share by Application (2021-2032)
6 Obesity Surgery Devices Regional Sales and Value Analysis
- 6.1 Global Obesity Surgery Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Obesity Surgery Devices Sales by Region (2021-2032)
- 6.2.1 Global Obesity Surgery Devices Sales by Region: 2021-2026
- 6.2.2 Global Obesity Surgery Devices Sales by Region (2027-2032)
- 6.3 Global Obesity Surgery Devices Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Obesity Surgery Devices Sales Value by Region (2021-2032)
- 6.4.1 Global Obesity Surgery Devices Sales Value by Region: 2021-2026
- 6.4.2 Global Obesity Surgery Devices Sales Value by Region (2027-2032)
- 6.5 Global Obesity Surgery Devices Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Obesity Surgery Devices Sales Value (2021-2032)
- 6.6.2 North America Obesity Surgery Devices Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Obesity Surgery Devices Sales Value (2021-2032)
- 6.7.2 Europe Obesity Surgery Devices Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Obesity Surgery Devices Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Obesity Surgery Devices Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Obesity Surgery Devices Sales Value (2021-2032)
- 6.9.2 South America Obesity Surgery Devices Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Obesity Surgery Devices Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Obesity Surgery Devices Sales Value Share by Country, 2025 VS 2032
7 Obesity Surgery Devices Country-level Sales and Value Analysis
- 7.1 Global Obesity Surgery Devices Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Obesity Surgery Devices Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Obesity Surgery Devices Sales by Country (2021-2032)
- 7.3.1 Global Obesity Surgery Devices Sales by Country (2021-2026)
- 7.3.2 Global Obesity Surgery Devices Sales by Country (2027-2032)
- 7.4 Global Obesity Surgery Devices Sales Value by Country (2021-2032)
- 7.4.1 Global Obesity Surgery Devices Sales Value by Country (2021-2026)
- 7.4.2 Global Obesity Surgery Devices Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.9.2 France Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.16.2 China Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.19.2 India Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Obesity Surgery Devices Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Obesity Surgery Devices Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Obesity Surgery Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Allergan
- 8.1.1 Allergan Company Information
- 8.1.2 Allergan Business Overview
- 8.1.3 Allergan Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Allergan Obesity Surgery Devices Product Portfolio
- 8.1.5 Allergan Recent Developments
- 8.2 Apollo Endosurgery
- 8.2.1 Apollo Endosurgery Company Information
- 8.2.2 Apollo Endosurgery Business Overview
- 8.2.3 Apollo Endosurgery Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Apollo Endosurgery Obesity Surgery Devices Product Portfolio
- 8.2.5 Apollo Endosurgery Recent Developments
- 8.3 Aspire Bariatrics
- 8.3.1 Aspire Bariatrics Company Information
- 8.3.2 Aspire Bariatrics Business Overview
- 8.3.3 Aspire Bariatrics Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Aspire Bariatrics Obesity Surgery Devices Product Portfolio
- 8.3.5 Aspire Bariatrics Recent Developments
- 8.4 IntraPace
- 8.4.1 IntraPace Company Information
- 8.4.2 IntraPace Business Overview
- 8.4.3 IntraPace Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.4.4 IntraPace Obesity Surgery Devices Product Portfolio
- 8.4.5 IntraPace Recent Developments
- 8.5 Intuitive Surgical
- 8.5.1 Intuitive Surgical Company Information
- 8.5.2 Intuitive Surgical Business Overview
- 8.5.3 Intuitive Surgical Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Intuitive Surgical Obesity Surgery Devices Product Portfolio
- 8.5.5 Intuitive Surgical Recent Developments
- 8.6 Mediflex Surgical Product
- 8.6.1 Mediflex Surgical Product Company Information
- 8.6.2 Mediflex Surgical Product Business Overview
- 8.6.3 Mediflex Surgical Product Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Mediflex Surgical Product Obesity Surgery Devices Product Portfolio
- 8.6.5 Mediflex Surgical Product Recent Developments
- 8.7 MetaCure
- 8.7.1 MetaCure Company Information
- 8.7.2 MetaCure Business Overview
- 8.7.3 MetaCure Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.7.4 MetaCure Obesity Surgery Devices Product Portfolio
- 8.7.5 MetaCure Recent Developments
- 8.8 Semiled
- 8.8.1 Semiled Company Information
- 8.8.2 Semiled Business Overview
- 8.8.3 Semiled Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Semiled Obesity Surgery Devices Product Portfolio
- 8.8.5 Semiled Recent Developments
- 8.9 Spatz FGIA
- 8.9.1 Spatz FGIA Company Information
- 8.9.2 Spatz FGIA Business Overview
- 8.9.3 Spatz FGIA Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Spatz FGIA Obesity Surgery Devices Product Portfolio
- 8.9.5 Spatz FGIA Recent Developments
- 8.10 TransEnterix
- 8.10.1 TransEnterix Company Information
- 8.10.2 TransEnterix Business Overview
- 8.10.3 TransEnterix Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.10.4 TransEnterix Obesity Surgery Devices Product Portfolio
- 8.10.5 TransEnterix Recent Developments
- 8.11 USGI Medical
- 8.11.1 USGI Medical Company Information
- 8.11.2 USGI Medical Business Overview
- 8.11.3 USGI Medical Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.11.4 USGI Medical Obesity Surgery Devices Product Portfolio
- 8.11.5 USGI Medical Recent Developments
- 8.12 Medtronic
- 8.12.1 Medtronic Company Information
- 8.12.2 Medtronic Business Overview
- 8.12.3 Medtronic Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Medtronic Obesity Surgery Devices Product Portfolio
- 8.12.5 Medtronic Recent Developments
- 8.13 Johnson & Johnson
- 8.13.1 Johnson & Johnson Company Information
- 8.13.2 Johnson & Johnson Business Overview
- 8.13.3 Johnson & Johnson Obesity Surgery Devices Sales, Value and Gross Margin (2021-2026)
- 8.13.4 Johnson & Johnson Obesity Surgery Devices Product Portfolio
- 8.13.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Obesity Surgery Devices Value Chain Analysis
- 9.1.1 Obesity Surgery Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Obesity Surgery Devices Sales Mode & Process
- 9.2 Obesity Surgery Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Obesity Surgery Devices Distributors
- 9.2.3 Obesity Surgery Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst